SCHEMBL7035965

SCHEMBL7035965

Cc1ccc(OC(=O)N[C@@H](CNC(=O)c2ccc(OCCNc3ncccn3)cc2O)C(=O)O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
POLB P06746 2/20 0.44
ITGB3 P05106 5/20 0.39
ITGAV P06756 4/20 0.39
ITGB1 P05556 3/20 0.39
ITGA5 P08648 3/20 0.39
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
EGLN2 Q96KS0 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
GAA P10253 1/20 0.36
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7039296 0.94 ITGB1 (0.41) MEN1KMT2APOLBITGB3ITGAV
SCHEMBL7038444 0.93 ITGB3 (0.39) MEN1KMT2APOLBITGB3ITGAV
SCHEMBL7036629 0.90 EGLN2 (0.39) MEN1KMT2APOLBITGB3ITGAV
SCHEMBL7032427 0.90 ITGB3 (0.41) MEN1KMT2APOLBITGB3ITGAV
SCHEMBL7031208 0.88 POLB (0.43) MEN1KMT2APOLBITGB3ITGAV
SCHEMBL7038878 0.88 ITGB3 (0.38) MEN1KMT2APOLBITGB3ITGAV
SCHEMBL7038923 0.87 ITGB3 (0.40) MEN1KMT2APOLBITGB3ITGAV
SCHEMBL7030553 0.86 ITGB3 (0.46) MEN1KMT2APOLBITGB3ITGAV
SCHEMBL7032608 0.86 ITGB3 (0.42) ITGB3ITGAVITGB1ITGA5MAPK1
SCHEMBL7035435 0.86 ITGB3 (0.40) MEN1KMT2APOLBITGB3ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030186967-A1 Acylresorcinol derivatives are selective vitronectin receptor inhibitors AMERICAN HOME PRODUCTS CORPORATION (US) 2003-10-02 US claimed
US-20030186967-A1 Acylresorcinol derivatives are selective vitronectin receptor inhibitors AMERICAN HOME PRODUCTS CORPORATION (US) 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186967-A1 Acylresorcinol derivatives are selective vitronectin receptor inhibitors ASGR1, TEK, APLNR MEN1 1162/4885KMT2A 3514/4885POLB 3397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.